Signals, Powered By EquityPandit
The US health regulator has provided its approval to Strides Shasun for Ranitidine tablets that are used in the treatment of intenstinal and stomach uclers and gastroesophageal reflux disease.
Strides Shasun has said in a statement that “it has received approval from the US Food and Drug Administration (USFDA) for Ranitidine tablets USP, 150 mg and 300 mg.”
The product will be manufactured at its Cuddalore and Pondicherry facilities.
